These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28868995)

  • 1. Central line-associated bloodstream infections in Australian ICUs: evaluating modifiable and non-modifiable risks in Victorian healthcare facilities.
    Spelman T; Pilcher DV; Cheng AC; Bull AL; Richards MJ; Worth LJ
    Epidemiol Infect; 2017 Oct; 145(14):3047-3055. PubMed ID: 28868995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central line-associated bloodstream infections in Australian intensive care units: Time-trends in infection rates, etiology, and antimicrobial resistance using a comprehensive Victorian surveillance program, 2009-2013.
    Worth LJ; Spelman T; Bull AL; Brett JA; Richards MJ
    Am J Infect Control; 2015 Aug; 43(8):848-52. PubMed ID: 26026826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral line-associated bloodstream infections in Australian neonatal and paediatric intensive care units: findings from a comprehensive Victorian surveillance network, 2008-2016.
    Worth LJ; Daley AJ; Spelman T; Bull AL; Brett JA; Richards MJ
    J Hosp Infect; 2018 May; 99(1):55-61. PubMed ID: 29222036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?
    Rock C; Thom KA; Harris AD; Li S; Morgan D; Milstone AM; Caffo B; Joshi M; Leekha S
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):143-8. PubMed ID: 26493213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal interventions for bundle implementation to decrease central line-associated bloodstream infections in adult intensive care units in a teaching hospital in Taiwan, 2009-2013.
    Lin WP; Chang YC; Wu UI; Hung MC; Chuang PY; Wang JT; Sheng WH; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):644-651. PubMed ID: 28888825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
    Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-Year Hospital-Wide Surveillance of Central Line-Associated Bloodstream Infections in a Korean Hospital.
    Seo HK; Hwang JH; Shin MJ; Kim SY; Song KH; Kim ES; Kim HB
    J Korean Med Sci; 2018 Nov; 33(45):e280. PubMed ID: 30402047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central-Line-Associated Bloodstream Infections in Québec Intensive Care Units: Results from the Provincial Healthcare-Associated Infections Surveillance Program (SPIN).
    Li L; Fortin E; Tremblay C; Ngenda-Muadi M; Quach C;
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1186-94. PubMed ID: 27430754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year surveillance of central line-associated bloodstream infections in South Korea: Surveillance not enough, action needed.
    Kim EJ; Kang SY; Kwak YG; Kim SR; Shin MJ; Yoo HM; Han SH; Kim DW; Choi YH;
    Am J Infect Control; 2020 Mar; 48(3):285-289. PubMed ID: 31493935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units: a 6-year review.
    Fontela PS; Platt RW; Rocher I; Frenette C; Moore D; Fortin E; Buckeridge D; Pai M; Quach C
    Am J Infect Control; 2012 Apr; 40(3):221-6. PubMed ID: 21824682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
    Oh JY; Cunningham MC; Beldavs ZG; Tujo J; Moore SW; Thomas AR; Cieslak PR
    Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a bundle of measures for reducing central line-associated bloodstream infections.
    Hernández-Aceituno A; Vega-Costa V; Ruiz-Álvarez M; Figuerola-Tejerina A; Méndez-Hernández R; Ramasco-Rueda F
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 May; 67(5):227-236. PubMed ID: 32216956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinational prospective cohort study of incidence and risk factors for central line-associated bloodstream infections over 18 years in 281 ICUs of 9 Asian countries.
    Rosenthal VD; Yin R; Rodrigues C; Myatra SN; Divatia JV; Biswas SK; Shrivastava AM; Kharbanda M; Nag B; Mehta Y; Sarma S; Todi SK; Bhattacharyya M; Bhakta A; Gan CS; Low MSY; Bt Madzlan Kushairi M; Chuah SL; Wang QY; Chawla R; Jain AC; Kansal S; Bali RK; Arjun R; Davaadagva N; Bat-Erdene I; Begzjav T; Mohd Basri MN; Tai CW; Lee PC; Tang SF; Sandhu K; Badyal B; Arora A; Sengupta D; Tao L; Jin Z
    J Vasc Access; 2024 Sep; 25(5):1508-1518. PubMed ID: 37151085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care.
    Lin KY; Cheng A; Chang YC; Hung MC; Wang JT; Sheng WH; Hseuh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2017 Jun; 50(3):339-348. PubMed ID: 26316008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-center prospective study on central line-associated bloodstream infections in 79 ICUs of China.
    Zeng C; Wu A; Li L; Jia H
    BMC Infect Dis; 2021 Dec; 21(1):1208. PubMed ID: 34863108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries.
    Rosenthal VD; Maki DG; Rodrigues C; Alvarez-Moreno C; Leblebicioglu H; Sobreyra-Oropeza M; Berba R; Madani N; Medeiros EA; Cuéllar LE; Mitrev Z; Dueñas L; Guanche-Garcell H; Mapp T; Kanj SS; Fernández-Hidalgo R;
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1264-72. PubMed ID: 21029008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.
    Baier C; Linke L; Eder M; Schwab F; Chaberny IF; Vonberg RP; Ebadi E
    PLoS One; 2020; 15(1):e0227772. PubMed ID: 31978169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.